Kyntra Bio (KYNB) Minority Interest (2014 - 2026)
Kyntra Bio (KYNB) posted Minority Interest of $21.5 million for Q1 2026, little changed sequentially from $21.5 million in Q4 2025, and little changed YoY from $21.5 million in Q1 2025.
Kyntra Bio (KYNB) Minority Interest (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Minority Interest for 13 years, with the latest figure at $21.5 million in Q1 2026.
- Quarterly Minority Interest changed 0.0% year-over-year to $21.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $21.5 million, changed 0.0% from the prior year.
- Minority Interest steadied at $21.5 million in Q1 2026 per KYNB's latest filing, from $21.5 million in the prior quarter.
- Over five years, Minority Interest peaked at $21.5 million in Q2 2023 and troughed at $20.0 million in Q1 2022.
- A 5-year average of $21.1 million and a median of $21.5 million in 2023 frame the typical range for Minority Interest.
- The widest YoY moves for Minority Interest: up 7.58% in 2023, down 0.0% in 2023.
- Over 5 years, Minority Interest stood at $20.0 million in 2022, then advanced by 7.58% to $21.5 million in 2023, then changed by 0.0% to $21.5 million in 2024, then changed by 0.0% to $21.5 million in 2025, then changed by 0.0% to $21.5 million in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered $21.5 million, $21.5 million, and $21.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.48 Mn |
| Mar 31, 2026 | 21.48 Mn |
| Dec 31, 2025 | 21.48 Mn |
| Sep 30, 2025 | 21.48 Mn |
| Jun 30, 2025 | 21.48 Mn |
| Mar 31, 2025 | 21.48 Mn |
| Dec 31, 2024 | 21.48 Mn |
| Sep 30, 2024 | 21.48 Mn |
| Jun 30, 2024 | 21.48 Mn |
| Mar 31, 2024 | 21.48 Mn |
| Dec 31, 2023 | 21.48 Mn |
| Sep 30, 2023 | 21.48 Mn |
| Jun 30, 2023 | 21.48 Mn |
| Mar 31, 2023 | 19.97 Mn |
| Sep 30, 2022 | 19.97 Mn |
| Jun 30, 2022 | 19.97 Mn |
| Mar 31, 2022 | 19.97 Mn |
| Dec 31, 2021 | 19.97 Mn |
| Sep 30, 2021 | 19.27 Mn |
| Jun 30, 2021 | 19.27 Mn |